Clinical Trials Directory

Trials / Completed

CompletedNCT03996031

Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic

Plan to Thrive: Extending Cancer Survivorship Care Beyond the Clinic Using a Smartphone-enabled Monitoring, Navigation and Tailored Intervention Program

Status
Completed
Phase
Study type
Observational
Enrollment
33 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the usability of the Plan To Thrive smartphone application with cancer survivors. This study will involve three visits (baseline, follow-up, and feedback assessments). Between the baseline and follow-up time points, patients will undergo a 90-day period in which they will engage with app content. It is hypothesized that cancer survivors in this study will find the smartphone application, Plan to Thrive, an acceptable and feasible way to access post-treatment information. In addition, the investigators will explore preliminary efficacy by examining changes over time in primary (patient activation, patient knowledge and adherence to follow-up care recommendations and health behaviors) and secondary outcomes \[symptom burden, health-related quality of life and patient satisfaction\].

Conditions

Interventions

TypeNameDescription
DEVICEPlan to Thrive smartphone applicationAll participants in this single-arm pilot study will receive access to Plan to Thrive. This mobile care management program is comprised of modules including educational interventions, health behavior trackers containing built-in reminders, symptom monitoring, and navigator services (see attached content). Access to intervention modules and individualized navigator services according to patients' needs as captured by 1) their patient-reported outcome (PRO) assessments via Plan to Thrive's symptom monitoring feature, and 2) patient requests.

Timeline

Start date
2019-08-19
Primary completion
2019-12-23
Completion
2019-12-31
First posted
2019-06-24
Last updated
2020-09-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03996031. Inclusion in this directory is not an endorsement.